Pattern and outcome of neuroblastoma a 10 year study

Indian Pediatrics

Volumn 35, Issue 3, 1998, Pages 223-229

  Kusumakumary, P ^a,b   Ajithkumar, T V ^a   Ratheesan, K ^a   Chellam, V G ^b   Krishan Nair, M ^a  

^a REGIONAL CANCER CENTRE   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Neuroblastoma; Survival

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE MARROW TOXICITY; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROBLASTOMA; NEUTROPENIA; TREATMENT OUTCOME;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; INDIA; INFANT; MALE; NEOPLASM STAGING; NEUROBLASTOMA; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0031925189     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brodeur GM, Seeger RC, Barett A, Berthold F, Castleberry RP, D'Angio G, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874-1881.
2. Hayes FA, Smith EI. Neuroblastoma. In: Principles and Practice of Pediatric Oncology. Eds. Pizzo PA, Poplack G. Philadelphia, J.B. Lippincott Co, 1989; pp 607-622.
3. Shaw PJ, Eden J. Neuroblastoma with intracranial involvement. An ENSG study. Med Pediatr Oncol 1992; 20: 149-155.
4. Kusumakumari P, Surendran N, Chellam VG, Pillai GR, Ramachandran K. Neuroblastoma with testicular metastasis. Indian J Cancer 1994; 31: 52-55.
5. Nitschke R, Smith EI, Shochat S, Altshuler G, Travers H, Shuster JJ, et al. Localised neuroblastoma treated by surgery. A POG study. J Clin Oncol 1988; 6: 1271-1279
6. Evans AE, D'Angio GJ, Koop CE. The role of multimodal therapy in patients with local and regional neuroblastoma. J Pediatr Surg 1984; 19: 77-80.
7. Dini G, Lanino E, Garavanta A, Roger D, Dallorso S, Viscoli C, et al. Myeloablative therapy and unpurged autologous bone marrow transplant in advanced neuroblastoma. J Clin Oncol 1991; 9: 1045-1049.
8. Philip T, Bernard JL Zucker JM, Pinkerton R, Lutz P, Bordigoni P, et al. High dose chemotherapy with bone marrow transplantation as consolidation 'treatment in neuroblastoma. An unselected group of stage IV patients over one year of age. J Clin Oncol 1987; 5: 266-271.
9. Haase GM, Wong KY, de Lorimier AA, Sather HN, Hammond GD. Improvement in survival after excision of primary in stage III neuroblastoma. J Pediatr Surg 1989; 24: 194-200.
10. West DC, Shamberger RC, Macklis RM, Kozakewich HPV, Wayne AS, Kreissman SG, et al. Stage III neuroblastoma more than 1 year of age at diagnosis. Improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 1993; 11: 84-90.
11. Garaventa A, De Bernadi B, Pianca C, Llomblast A, Donfranscesco A, Cordero di Montezemolo L, et al. Localised but unresectable neuroblastoma. Treatment and outcome of 145 cases. J Clin Oncol 1993; 11: 1770-1779.
12. Castle V, Badal MD, Bezanilla JC, Llomblast A, Ruiz-Jimenez JI, Sanchez de Toledo J, et al. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy. A report from neuroblastoma group of Spanish Society of Pediatric Oncology. Med Pediatr Oncol 1995; 24: 29-35.
13. Breslow N, Mc Cann B. Statistical estimation of prognosis for children wtih neuroblastoma. Cancer Res 1971; 31: 2098-2103.
14. Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD. Excellent outcome of Stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. 1989; 7: 236-244.
15. Tsuchida Y, Yokoyama J, Kaneko, Uchino J, Iniafuchi M, Makino S, et al. Therapeutic significance of surgery in advanced neuroblastoma. A report from study group of Japan. J Pediatr Surg 1992; 27: 616-622.
16. Shamberger RC, Allarde-Seg Undo A, Kozakewich HPW, Grier HE. Surgical management of stage III and IV neuroblastoma. Resection before or after chemotherapy. J Pediatr Surg 1991; 26: 1113-1118.
17. Ikeda K, Nakagawara A, Yano H, Akiyama H, Tasaka H, Ueda K, et al. Improved survival rates in children more than 1 year with stage III or IV neuroblastoma following intensive chemotherapy regimen. J Pediatr Surg 1989; 24: 189-193.
18. Kushner BH, Cheung NV, La Quaglia MP. Ambrose PF, Ambrose IM, Bonilla MA, et al. Survival from locally invasive or widespread neuroblastoma without cy-totoxic therapy. J Clin Oncol 1996; 14: 373-381.
19. Castlebery RP, Kun LE, Shuster JJ, Altshuler G, Smith IE, Nitschke R, et al. Radiotherapy improves the outlook for patients older than 1 year with POG stage C neuroblastoma. J Clin Oncol 1991; 9: 789-795.
20. Berthold F, Trechow R, Utsch S, Zieschang J. Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992; 14: 207-215.
21. Hann HWL, Evan AE, Siegel SE, Wond KY, Sather H, Dalton A, et al. Prognostic importance of serum ferritin in patients with stage III and IV neuroblastoma. The children cancer study group experience. Cancer Res 1985; 45: 2843-2848.
22. Zeltzer PM, Merangos PJ, Evan AE, Schneider SL. Serum neuron specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 1986; 57: 1230-1234.
23. Brodeur GM. TRK-A expression in neuroblastoma. A new prognostic marker with biological and clinical significance. J NCI 1993; 157: 344-345.
24. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121-1124.